Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Am J Infect Control ; 42(5): 571-3, 2014 May.
Article in English | MEDLINE | ID: mdl-24773800

ABSTRACT

Chlorhexidine gluconate (CHG) decreases hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) that can cause colonization and infection. A standard approach is the bathing of all patients with CHG to prevent MRSA transmission. To decrease CHG utilization, this study assessed selective daily administration of CHG bathing to intensive care unit patients who had an MRSA-positive result or a central venous catheter. This risk-based approach was associated with a 72% decrease in hospital-acquired MRSA transmission rate.


Subject(s)
Baths/methods , Chlorhexidine/analogs & derivatives , Cross Infection/prevention & control , Disinfectants/therapeutic use , Disinfection/methods , Methicillin-Resistant Staphylococcus aureus/isolation & purification , Staphylococcal Infections/prevention & control , Chlorhexidine/therapeutic use , Cross Infection/microbiology , Cross Infection/transmission , Disease Transmission, Infectious/prevention & control , Health Services Research , Humans , Intensive Care Units , Risk Management/methods , Staphylococcal Infections/microbiology , Staphylococcal Infections/transmission , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL